Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Colorectal Cancer Screening Tests Market Overview
The colorectal cancer screening tests market size was valued at $1.25 billion in 2023. Factors such as the release of various new devices, including fecal DNA testing kits, will drive the market growth during the forecast period. Thus, the colorectal cancer screening tests market will grow at a CAGR of more than 7% from 2023 to 2033. Colorectal cancer screening tests are carried out to monitor the bowel health of at-risk individuals to detect and treat it in a timely.
Colorectal Cancer Screening Tests Market Outlook 2023-2033 ($ Billion)
Buy the Full Report for More Insights on the Colorectal Cancer Screening Tests Market Forecast, Download a Free Sample Report
The colorectal cancer screening tests market research report identifies quantitative market trends within in vitro diagnostics therapeutic areas. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also provides an in-depth discussion of COVID-19’s effects on the colorectal cancer screening tests market for 2020 and beyond. Furthermore, the report provides colorectal cancer screening tests market share by company that will help in identifying untapped market opportunities.
Market Size (2023) | $1.25 billion |
CAGR (2023-2033) | >7% |
Historic Period | 2015-2022 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Colorectal Cancer Screening Tests Market Segments
The key segments in the colorectal cancer screening tests market are Fecal DNA Test Kits, Guaiac Fecal Occult Blood Test (gFOBT) Kits, Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits, and other Colorectal Cancer Screening Tests. In 2023, the Fecal DNA Test Kits segment had the highest CRC screening tests market share. The segment will continue its dominance during the projected period.
Fecal DNA Testing Kits are multitarget tests that measure various biomarkers. The biomarkers include quantitative assays for specific DNA alterations such as Kirsten rat sarcoma virus (KRAS) mutations and methylation of bone morphogenetic protein 3 (BMP3), which are found in cancerous tumors or precancerous polyps. Fecal DNA testing kits can also detect the presence of hemoglobin.
The Guaiac Fecal Occult Blood Test (gFOBT) kit is a test used to detect fecal occult blood or blood in the feces or stool. This test can be carried out in a home setting by placing a stool sample on a test card coated with guaiac. The card changes color if blood is in the stool, through the heme protein in blood catalyzing the oxidation of alpha-guaiaconic acid found in the paper, to blue quinone. The card is then returned to the prescribing physician or the lab for interpretation. Some guaiac-based FOBTs use flushable pads instead of a card.
Colorectal Cancer Screening Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Insights into the Colorectal cancer screening tests Market Segments, Download a Free Sample Report
Colorectal Cancer Screening Tests Market Segmentation by Regions
The key regions in the colorectal cancer screening tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, the North American colorectal cancer screening tests market was the leading regional segment.
The North American CRC screening market is expected to grow during the forecast period. Factors such as growth in the geriatric population, improved disease awareness, and a surge in the percentage of asymptomatic cases will drive the market growth.
The US CRC screening market follows regional trends for North America and will experience significant growth during the forecast period. The national campaigns targeted at increasing CRC disease awareness and improvements in non-invasive test options will propel the market growth.
Colorectal Cancer Screening Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Colorectal Cancer Screening Tests Market, Download a Free Sample Report
Colorectal Cancer Screening Tests Market – Competitive Landscape
In 2023, Exact Sciences colorectal cancer screening tests market share was the highest
The key companies in the colorectal cancer screening tests market are:
- Exact Sciences Corp
- Danaher Corp
- Eiken Chemical Co Ltd
- Sentinel CH. SpA
- Resonac Corporation
Companies are investing in training and education schemes to promote CRC disease awareness in potential countries that can implement more comprehensive screening strategies. This is also helping them promote their brand or type of devices among physicians.
Companies with iFOBT or FIT devices are planning to partner with government organizations, third-party distributors, and physician societies. This will ensure that their device is adopted within national screening programs, which have the potential for high volumes of sales.
Colorectal Cancer Screening Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company-Wise Insights into the Colorectal Cancer Screening Tests Market, Download a Free Sample Report
Colorectal Cancer Screening Tests Market Dynamics
Trends: Factors such as aging populations and increasing disease awareness will drive the CRC screening tests market growth. Implementation of numerous national screening campaigns indicates that the market is expected to grow across all regions during the forecast years.
Future Outlook: The release of new devices, such as fecal DNA testing kits and blood-based assays for CRC screening will boost the market growth during the forecast years.
Buy the Full Report for Additional Colorectal Cancer Screening Tests Market Dynamics, Download a Free Sample Report
Segments Covered in this Report.
Colorectal Cancer Screening Tests Segment Outlook ($ Million, 2015-2033)
- Fecal DNA Test Kits
- Guaiac Fecal Occult Blood Test (gFOBT) Kits
- Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits
- Other Colorectal Cancer Screening Tests
Colorectal Cancer Screening Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are:
The colorectal cancer screening tests market research report includes an insightful review of the key industry trends.
- The colorectal cancer screening tests market report offers annualized market revenue details by segment and market outlooks from 2015-2033.
- The report also includes market-level data on units, average selling prices, and market values.
Regional, country, and global colorectal cancer screening tests market insights:
- The colorectal cancer screening tests market share report offers qualitative insights into global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- Colorectal cancer screening tests market SWOT analysis.
- The report provides trends and colorectal cancer screening tests market competitive dynamics.
Buy the Full Report for More Insights into the Colorectal Cancer Screening Tests Market Share, Download a Free Sample Report
Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources, including databases of government procedures and hospital purchasing.
Companies covered: Eiken Chemical Co Ltd, Sentinel CH. SpA, Alfresa Pharma Corp, Showa Denko Materials Co Ltd, Danaher Corp, Hemosure Inc, Medline Industries Inc, QuidelOrtho Corp, Sekisui Diagnostics LLC, Epigenomics AG, Exact Sciences Corp, Aerscher Diagnostics LLC, Thermo Fisher Scientific Inc, Boditech Med Inc, McKesson Corp, Propper Manufacturing Co Inc, and others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
- Extensive coverage of the colorectal cancer screening tests market under development.
- An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
- Reviews of major players involved in the development of the colorectal cancer screening tests market and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Key clinical trial data of ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
- Understand the COVID-19 impact on colorectal cancer.
- Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving colorectal cancer.
- Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.
- Formulate effective sales and marketing strategies with a detailed evaluation of colorectal cancer screening tests market share by company. Identify strong competitors and create winning strategies to stand out in the global colorectal cancer screening tests market.
- Track regional colorectal cancer screening tests market sales as well as country-specific transactions from 2015-2033.
- Organize your sales and marketing efforts by identifying the global colorectal cancer screening tests market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.
Sentinel CH. SpA
Alfresa Pharma Corp
Resonac Corp
Danaher Corp
Hemosure Inc
Medline Industries Inc
QuidelOrtho Corp
Sekisui Diagnostics LLC
Epigenomics AG
Exact Sciences Corp
Aerscher Diagnostics LLC
Thermo Fisher Scientific Inc
Boditech Med Inc
McKesson Corp
Propper Manufacturing Co Inc
Others
Frequently asked questions
-
What was the colorectal cancer screening tests market size in 2023?
The colorectal cancer screening tests market size was $1.25 billion in 2023.
-
What will the colorectal cancer screening tests market CAGR be during 2023-2033?
The colorectal cancer screening tests will grow at a CAGR of more than 7% during 2023-2033.
-
Which was the leading segment in the colorectal cancer screening tests market in 2023?
The fecal DNA test kits segment was leading the colorectal cancer screening tests market in 2023.
-
Which region held the largest share of the colorectal cancer screening tests market in 2023?
North America was the largest regional market for colorectal cancer screening tests in 2023.
-
Which are the leading players in the colorectal cancer screening tests market?
The key companies in the colorectal cancer screening tests market are Exact Sciences Corp, Danaher Corp, Eiken Chemical Co Ltd, Sentinel CH. SpA, and Resonac Corporation among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.